Launched in partnership with the National Institutes of Health (NIH), the Institute of Medicine (IOM), the Russian Academy of Medical Sciences (RAMS) and the Russian Academy of Sciences (RAS), the November Forum included participation and additional support from Amgen, Amway, Celgene, The Coca-Cola Company, Genzyme, Merck, Novartis and Roche.
 
The three day meeting featured distinguished researchers from the United States and the Russian Federation led by Scott E. Campbell, Former Executive Director and CEO of the FNIH; Roger I. Glass, Director of the Fogarty International Center at the NIH; Nils Daulaire, Director, Office of Global Affairs, Office of the Secretary, Department of Health and Human Services (HHS); Anatoly Grigoriev, Vice-President of the Russian Academy of Sciences; Veronika Skvortsova, Deputy Minister, Ministry of Health and Social Development of the Russian Federation (MOHSD) and Ivan Dedov, President of the Russian Academy of Medical Sciences (RAMS).

Meeting Agendas

Forum Agenda
Cancer Agenda
Active & Healthy Lifestyles Agenda
Human Development Agenda
Rare Diseases Agenda
Infectious Diseases Agenda
Brain Sciences Agenda
Presenters Bios
All Abstracts Forum Meeting Nov. 16-18, 2011

Photos from the 2011 US - Russia Scientific Forum
all photos ©Dmitry Chetverukhin under Creative Common license.

Selected Presentations

The following is a sampling of the presentations shown at the 2011 US - Russia Scientific Forum.  For additional presentations please contact Marya Levintova Ph.D. at marya [dot] levintova [at] nih [dot] gov.

Diagnosis and Treatment of Immune Deficiency in Extremely Low Birth Weight Preterm Neonates by Marina V. Degtyareva
U.S. – Russia Scientific Forum Rare Diseases by David Adams, MD, PhD
Partnerships: Catalysts To Promote  Active, Healthy Lifestyles by Rhona S. Applebaum, PhD
Genome, Transcriptome And Proteome Features Of Malignant Cells As a Source of Combinatorial Biomarkers For Clinical Translation by Ancha Baranova
World-Wide Physical Inactivity: Scope of the Problem and What to Do about it by Steven N. Blair
Postpartum Hemorrhage: The Leading Cause of Maternal Mortality by Richard J. Derman, MD, MPH
Modular Nanotransporters of Anti-Cancer Pharmaceuticals by Georgiev
Assistive Reproductive Technologies (ART) Outcomes Optimization Thought PGD: Role of Medico-genetic Factors by Zhanna Glinkina
Alcohol-Impaired Driving and Other Injury Prevention: From Global to Local by Ralph Hingson, Sc.D., M.P.H.
Recent Expansion of Newborn Screening by R. Rodney Howell, M. D.
Surveillance Methodologies Utilized within NHANES with Emphasis on Identification of Non-communicable Chronic Disease by Van S. Hubbard, M.D., Ph.D. and Clifford L. Johnson, M.S.P.H.
Bioinformatic Treatment of Human Metabolome Profile for Diagnostics Dr. Petr Lokhov  & Dr. Alexander Archakov
Alcohol Abuse and the Problem for Research in Russia by Alexandr Nemtsov
Approach to Rare Diseases Research and Orphan Products Development by John J. Orloff, MD
Stress Markers and Effects of Minor Bioactive Compounds on Heart Health Risk Factors by R. Keith Randolph PhD and Victor A. Tutelyan, MD, PhD
Making the Connection Between Physical Activity and Health by Robert E. Sallis, MD, FACSM, FAAFP
Molecular Physiology Insight In Overcoming Multidrug Resistance by Evgenii S. Severin
Modular Nanotransporters: A Multi-purpose Platform for Cell-specific Intranuclear Drug Delivery by Alexander S. Sobolev
Maternal-Fetal Surgery for Myelomeningocele by Catherine Y Spong, MD
Progesterone Supplementation and Prevention of Preterm Birth by Catherine Y Spong, MD
The Impact of Assisted Reproductive Technologies on Maternal-Child Health by Geeta K. Swamy, MD
Effect Of Physical Activity On Cognitive Functions: Molecular-Genetic And Brain Mechanisms by Tonevitsky A.G., Smirnov K.S.
Combination Nanopreparations And Intracellular Targeting For Mdr Tumors by Vladimir Torchilin, Ph.D., D.Sc.
Prevention of Alcohol Exposed Pregnancies by Larissa Tsvetkova, PhD
Novel Strategy to Treat Chronic Bacterial Infections by Nailya Zigangirova and Anna Karyagina
Open Innovation, Networks, and Strategic Partnerships in Drug Discovery and Development by Andrew M. Dahlem, Ph.D.
Re-Engineering Early Phase Cancer Drug Development: Decreasing the Time from Novel Target to Novel Therapeutic by James H. Doroshow, M.D.

Founding Private Partner

Lead Sponsors

Supporting Sponsors

For additional information, please contact Ann Ashby, Deputy Executive Director, Foundation for the NIH, aashby [at] fnih [dot] org, 301-435-1641.
For press inquiries, please contact Kimberly O’Sullivan, Communications Officer, Foundation for the NIH, kosullivan [at] fnih [dot] org, 301-435-2613